1,732,958 research outputs found
Brian E. Stack
No full textBrian E. Stack passed at his home in Honolulu, Hawaii at the age of 77. Brian was raised in Palo Alto, CA and attended San Jose State University
Interview with Brian E. Coutts (FA 756)
No full textOral history interview with Brian E. Coutts, Head of the Department of Public Services at WKU Libraries, conducted by Lisa Karen Miller on 10 July 2013. This interview was part of the WKU Libraries Oral History Project. The audio interview can be accessed by clicking the Link to Full Text button. A photograph and a downloadable version can be accessed by clicking on Additional Files
Botulinum neurotoxin for head and neck disorders/ [edited by] Andrew Blitzer, Brian E. Benson, Diana N. Kirke
No full textIncludes bibliographical references and index"Senior author Dr. Andrew Blitzer is an internationally renowned pioneer on the use of botulinum neurotoxin for functional disorders, with unparalleled expertise on this topic. Joined by co-editors Brian Benson and Diana Kirke, with multidisciplinary contributors, Botulinum Neurotoxin for Head and Neck Disorders Second Edition fills a gap in the medical literature. The unique textbook focuses on the use of botulinum neurotoxins for functional disorders of the head and neck, though with some aesthetic indications. The second edition reflects the latest advances and understanding of existing and emerging applications for botulinum neurotoxins, including new treatment paradigms, revised pharmacology, and an updated review of the literature in all chapters. Twenty superbly illustrated chapters cover the management of hyperfunctional, pain, and hypersecretory syndromes of the head and neck. Hyperfunctional motor disorders are discussed in chapters focused on blepharospasm, facial dystonia, Meige syndrome, oromandibular dystonia, spasmodic dysphonia (laryngeal dystonia), and cervical dystonia. Specific treatment approaches for pain are addressed in chapters on migraine and chronic daily tension headaches, temporomandibular disorders, and trigeminal neuralgia. The treatment of autonomic nervous system disorders is covered in chapters dedicated to Frey syndrome, facial hyperhydrosis, and sialorrhea"--Pharmacology of Botulinum Neurotoxins / Muna I. Bitar, Nikita Kohli, Maya Samman, and Andrew Blitzer -- Botulinum Neurotoxin for Blepharospasm / Amit Patel, Andrew Blitzer, and Boris L. Bentsianov -- Botulinum Neurotoxin for Facial Dystonia / Scott M. Rickert, Amy P. Wu, and Andrew Blitzer Botulinum -- Neurotoxin for Meige Syndrome / Niv Mor and Andrew Blitzer -- Botulinum Neurotoxin for Oromandibular Dystonia / Daniel Novakovic and Ajay E. Chitkara -- Botulinum Neurotoxin for Spasmodic Dysphonia / Phillip C. Song, Lucian Sulica, and Andrew Blitzer -- Botulinum Neurotoxin for Cervical Dystonia / Tanya K. Meyer, Joel Guss, and Ronda E. Alexander -- Botulinum Neurotoxin for Hemifacial Spasm and Facial Synkinesis / Lesley French Childs, Daniel Novakovic, and Scott R. Gibbs -- Botulinum Neurotoxin for Hyperfunctional Facial Lines / Brian E. Benson, Diana N. Kirke, and Andrew Blitzer -- Botulinum Neurotoxin for Upper and Lower Esophageal Spasm / Nwanmegha Young and Brian E. Benson -- Botulinum Neurotoxin for Palatal Myoclonus / Ajay E. Chitkara, Catherine F. Sinclair, and Daniel Novakovic -- Botulinum Neurotoxin for Temporomandibular Disorders, Masseteric Hypertrophy, and Cosmetic Masseter Reduction / Michael Z. Lerner and Andrew Blitzer -- Botulinum Neurotoxin Therapy in the Laryngopharynx / Craig H. Zalvan, Phillip C. Song, Nwanmegha Young, and Andrew Blitzer -- Botulinum Neurotoxin for Migraine / Rachel Kaye, Jerome Schwartz, Brian E. Benson, and William J. Binder -- Botulinum Neurotoxin for Chronic Tension Headache / Nwanmegha Young and Brian E. Benson -- Botulinum Neurotoxin for Trigeminal Neuralgia / Elizabeth Guardiani, Andrew Blitzer, Lesley French Childs, and Ronda E. Alexander -- Botulinum Neurotoxin for Frey's Syndrome / Rachel Kaye, Andrew Blitzer, and Brian E. Benson -- Botulinum Neurotoxin for Facial Hyperhidrosis / Diana N. Kirke, Daniel Novakovic, and Andrew Blitzer -- Botulinum Neurotoxin for Sialorrhea / Brianna K. Crawley, Scott M. Rickert, Senja Tomovic, and Andrew Blitzer -- Botulinum Neurotoxin for Radiation-Induced Spasm and Pain / Diana N. Kirke, Brian E. Benson, and Tanya K. Meyer1 online resourc
Tyrosine-derived nanoparticles for the topical treatment of psoriasis
No full textAt the New Jersey Center for Biomaterials, a potential topical psoriasis therapy consisting of tyrosine-derived polymeric micelles (TyroSpheres™) with encapsulated drug has been developed. These TyroSpheres™ are composed of copolymers with hydrophobic blocks of oligomers of desaminotyrosyl tyrosine esters and diacids and hydrophilic blocks of poly(ethylene glycol). Encapsulated drugs include a vitamin D3 analogue, betamethasone dipropionate, and paclitaxel. Drug-loaded TyroSpheres™ offer: 1) reproducible particle sizes, 2) control of drug release rates, 3) enhancement of drug stability, 4) increased solubility by high encapsulation capacity, 5) lack of short-term cytotoxicity, and 6) the ability to improve drug delivery into the skin. Additionally, TyroSpheres™ can be incorporated into an elegant viscous formulation for skin application with no impact on homogeneity, release, or skin distribution. Analysis has revealed that TyroSpheres™ are stable for up to 4 months, significantly limiting their shelf-life potential. By implementing a rational design, research on the preparation of a dry formulation of TyroSpheresTM has been undertaken, resulting in a fully re-constitutable formulation that has demonstrated complete stability to date (6 months). A two year-long stability study has been initiated to track the properties of this formulation over time. TyroSpheres™ address the requirements of a pharmaceutically acceptable skin drug delivery carrier and offer potential in the treatment of psoriasis since they allow delivery of difficult to uptake drugs to skin strata where the disease originates.Ph. D.Includes bibliographical referencesby Brian E. Kilfoyl
Brian E. Daley, Gregory of Nazianzus, 2006
No full textSchamp Jacques. Brian E. Daley, Gregory of Nazianzus, 2006. In: L'antiquité classique, Tome 77, 2008. pp. 474-475
Brian E. Beddo
No full textSeries 328 | Board of Pardons | Prisoners' pardon application case files | Brian E. BeddoCase files consist of letters to the Governor, a formal application for a pardon, petitions and letters of support from the public and officials connected to the case. Cases illustrate the process of review by the board of cases of prisoners incarcerated in the Utah prison system to determine if they should be released before their regular sentence ended
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
